ENVESTNET ASSET MANAGEMENT INC

Position in CPRX — Catalyst Pharmaceuticals, Inc.

CIK 1407543 Berwyn, PA

Position in CPRX

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$2,936,536

+$1,472,815 QoQ

Shares Held

118,600

+89.1% QoQ

Ownership

0.097%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ENVESTNET ASSET MANAGEMENT INC holds $767,426,760 across 109 Biotechnology names. CPRX ranks #30 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	503,564	$224,861,468
2	REGN	Regeneron Pharmaceuticals, Inc.	109,152	$84,335,201
3	ALNY	Alnylam Pharmaceuticals, Inc.	171,797	$56,842,473
4	INSM	INSMED Inc	299,925	$49,043,736
5	ARGX	Argenx SE	61,418	$44,850,494
6	RPRX	Royalty Pharma plc	495,892	$23,787,939
7	GMAB	Genmab A/S	862,301	$23,135,535
8	ROIV	Roivant Sciences Ltd.	678,518	$18,794,948

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,936,536	118,600	+89.1%	Shares	Sole	2026-05-04
2025-12-31	$1,463,721	62,713	-36.9%	Shares	Sole	2026-02-10
2025-09-30	$1,957,589	99,370	-2.2%	Shares	Sole	2025-11-05
2025-06-30	$2,204,871	101,607	+29.9%	Shares	Sole	2025-08-01
2025-03-31	$1,896,228	78,195	+21.4%	Shares	Sole	2025-04-29
2024-12-31	$1,343,923	64,395	+162.2%	Shares	Sole	2025-02-13
2024-09-30	$488,232	24,559	-22.0%	Shares	Sole	2024-11-07
2024-06-30	$487,594	31,478	+4.5%	Shares	Sole	2024-08-08
2024-03-31	$479,985	30,112	-18.0%	Shares	Sole	2024-05-13
2023-12-31	$617,179	36,715	+59.6%	Shares	Sole	2024-02-13
2023-09-30	$268,975	23,009	+5.1%	Shares	Sole	2023-11-13
2023-06-30	$294,188	21,889	+16.8%	Shares	Sole	2023-08-04
2023-03-31	$310,642	18,736	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.